Cargando…

Setting health care services tariffs in Iran: half a century quest for a window of opportunity

BACKGROUND: The process of medical tariffs setting in Iran remains to be a contentious issue and is heavily criticized by many stakeholders. This paper explores the experience of setting health care services tariffs in the Iranian health care system over the last five decades. METHODS: We analyzed d...

Descripción completa

Detalles Bibliográficos
Autores principales: Doshmangir, Leila, Rashidian, Arash, Kouhi, Farhad, Gordeev, Vladimir Sergeevich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336437/
https://www.ncbi.nlm.nih.gov/pubmed/32631344
http://dx.doi.org/10.1186/s12939-020-01224-1
_version_ 1783554319280242688
author Doshmangir, Leila
Rashidian, Arash
Kouhi, Farhad
Gordeev, Vladimir Sergeevich
author_facet Doshmangir, Leila
Rashidian, Arash
Kouhi, Farhad
Gordeev, Vladimir Sergeevich
author_sort Doshmangir, Leila
collection PubMed
description BACKGROUND: The process of medical tariffs setting in Iran remains to be a contentious issue and is heavily criticized by many stakeholders. This paper explores the experience of setting health care services tariffs in the Iranian health care system over the last five decades. METHODS: We analyzed data collected through literature review and reviews of the official documents developed at the various levels of the Iranian health system using inductive and deductive content analysis. Twenty-two face-to-face semi-structured interviews supplemented the analysis. Data were analysed and interpreted using ‘policy triangle’ and ‘garbage can’ models. RESULTS: Our comprehensive review of changes in the medical tariff setting provides valuable lessons for major stakeholders. Most changes were implemented in a sporadic, inadequate, and a non-evidence-based manner. Disparities in tariffs between public and private sectors continue to exist. Lack of clarity in tariffs setting mechanisms and its process makes negotiations between various stakeholders difficult and can potentially become a source of a corrupt income. Such clarity can be achieved by using fair and technically sound tariffs. Technical aspects of tariff setting should be separated from the political negotiations over the overall payment to the medical professionals. Transparency regarding a conflict of interest and establishing punitive measures against those violating the rules could help improving trust in the doctor-patient relationship. CONCLUSION: Use of evidence-informed models and methods in medical tariff setting could help to strike the right balance in the process of health care services provision to address health system objectives. A sensitive application of policy models can offer significant insights into the nature of medical tariff setting and highlight existing constraints and opportunities. This study generates lessons learned in tariffs setting, particularly for low- and middle-income countries.
format Online
Article
Text
id pubmed-7336437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73364372020-07-07 Setting health care services tariffs in Iran: half a century quest for a window of opportunity Doshmangir, Leila Rashidian, Arash Kouhi, Farhad Gordeev, Vladimir Sergeevich Int J Equity Health Research BACKGROUND: The process of medical tariffs setting in Iran remains to be a contentious issue and is heavily criticized by many stakeholders. This paper explores the experience of setting health care services tariffs in the Iranian health care system over the last five decades. METHODS: We analyzed data collected through literature review and reviews of the official documents developed at the various levels of the Iranian health system using inductive and deductive content analysis. Twenty-two face-to-face semi-structured interviews supplemented the analysis. Data were analysed and interpreted using ‘policy triangle’ and ‘garbage can’ models. RESULTS: Our comprehensive review of changes in the medical tariff setting provides valuable lessons for major stakeholders. Most changes were implemented in a sporadic, inadequate, and a non-evidence-based manner. Disparities in tariffs between public and private sectors continue to exist. Lack of clarity in tariffs setting mechanisms and its process makes negotiations between various stakeholders difficult and can potentially become a source of a corrupt income. Such clarity can be achieved by using fair and technically sound tariffs. Technical aspects of tariff setting should be separated from the political negotiations over the overall payment to the medical professionals. Transparency regarding a conflict of interest and establishing punitive measures against those violating the rules could help improving trust in the doctor-patient relationship. CONCLUSION: Use of evidence-informed models and methods in medical tariff setting could help to strike the right balance in the process of health care services provision to address health system objectives. A sensitive application of policy models can offer significant insights into the nature of medical tariff setting and highlight existing constraints and opportunities. This study generates lessons learned in tariffs setting, particularly for low- and middle-income countries. BioMed Central 2020-07-06 /pmc/articles/PMC7336437/ /pubmed/32631344 http://dx.doi.org/10.1186/s12939-020-01224-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Doshmangir, Leila
Rashidian, Arash
Kouhi, Farhad
Gordeev, Vladimir Sergeevich
Setting health care services tariffs in Iran: half a century quest for a window of opportunity
title Setting health care services tariffs in Iran: half a century quest for a window of opportunity
title_full Setting health care services tariffs in Iran: half a century quest for a window of opportunity
title_fullStr Setting health care services tariffs in Iran: half a century quest for a window of opportunity
title_full_unstemmed Setting health care services tariffs in Iran: half a century quest for a window of opportunity
title_short Setting health care services tariffs in Iran: half a century quest for a window of opportunity
title_sort setting health care services tariffs in iran: half a century quest for a window of opportunity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336437/
https://www.ncbi.nlm.nih.gov/pubmed/32631344
http://dx.doi.org/10.1186/s12939-020-01224-1
work_keys_str_mv AT doshmangirleila settinghealthcareservicestariffsiniranhalfacenturyquestforawindowofopportunity
AT rashidianarash settinghealthcareservicestariffsiniranhalfacenturyquestforawindowofopportunity
AT kouhifarhad settinghealthcareservicestariffsiniranhalfacenturyquestforawindowofopportunity
AT gordeevvladimirsergeevich settinghealthcareservicestariffsiniranhalfacenturyquestforawindowofopportunity